Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application

Published:2018-10-06 Issue:2 Volume:7 Page:321-332
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Vo Pamela,Paris Nicolas,Bilitou Aikaterini,Valena Tomas,Fang Juanzhi,Naujoks Christel,Cameron Ann,de Reydet de Vulpillieres Frederic,Cadiou Francois

Funder

Novartis Pharma AG, Switzerland

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s40120-018-0113-0.pdf

Reference34 articles.

1. International Headache Society. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.

2. World Health Organization. Headache disorders. Fact sheet N°277. 2016. http://www.who.int/mediacentre/factsheets/fs277/en/ . Accessed 10 Jul 2017.

3. Charles A. The evolution of a migraine attack—a review of recent evidence. Headache. 2013;53:413–9.

4. Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301–15.

5. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–32.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 1;The Journal of Headache and Pain;2024-09-13

2. Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis;European Journal of Pharmacology;2024-08

3. Digitalisierung in der Migränetherapie;Fortschritte der Neurologie · Psychiatrie;2024-05-23

4. Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial;The Journal of Headache and Pain;2024-04-16

5. Implementing a digital solution for patients with migraine—Developing a methodology for comparing digitally delivered treatment with conventional treatment: A study protocol;PLOS Digital Health;2024-02-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3